Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Giudice, Jimena ^a,b,f   Barcos, Lucia Soledad ^a   Guaimas, Francisco F ^a   Penas Steinhardt, Alberto ^c   Giordano, Luciana ^d   Jares Erijman, Elizabeth A ^b   Coluccio Leskow, Federico ^a,e  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b CONICET ^*  (Argentina)

^c Instituto de Estudios de la Inmunidad Humoral   (Argentina)

^d MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^e DEPARTAMENTO DE CIENCIAS BÁSICAS   (Argentina)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Endocytosis; Insulin receptor; Insulin IGF II; Microscopy; Quantum dots; Signaling

Indexed keywords

CYAN FLUORESCENT PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR B; QUANTUM DOT; SOMATOMEDIN B; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CELL MEMBRANE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERNALIZATION; METABOLIC REGULATION; MITOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 84875520336     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-18     Document Type: Article

References (59)

1. Insulin through the ages: phylogeny of a growth promoting and metabolic regulatory hormone. Chan SJ, Steiner DF, Am Zool 2000 40 213 222 10.1668/0003-1569(2000)040[0213:ITTAPO]2.0.CO;2
2. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G, Science 1997 277 942 946 10.1126/science.277.5328.942 9252323 (Pubitemid 27366677)
3. Genetics of mouse growth. Efstratiadis A, Int J Dev. Biol 1998 42 955 976 9853827 (Pubitemid 28530752)
4. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Tissenbaum HA, Ruvkun G, Genetics 1998 148 703 717 9504918 (Pubitemid 28087620)
5. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Curr Biol 2001 11 213 221 10.1016/S0960-9822(01)00068-9 11250149 (Pubitemid 32185323)
6. Distinct and overlapping functions of insulin and IGF-I receptors. Nakae J, Kido Y, Accili D, Endocr Rev 2001 22 818 835 10.1210/er.22.6.818 11739335 (Pubitemid 34214297)
7. Insulin signalling and the regulation of glucose and lipid metabolism. Saltiel AR, Kahn CR, Nature 2001 414 799 806 10.1038/414799a 11742412 (Pubitemid 34000783)
8. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Nature 2003 421 182 187 10.1038/nature01298 12483226 (Pubitemid 36090987)
9. Testis determination requires insulin receptor family function in mice. Nef S, Verma-Kurvari S, Merenmies J, Vassalli JD, Efstratiadis A, Nature 2003 426 291 295 10.1038/nature02059 14628051 (Pubitemid 37463147)
10. The Drosophila insulin receptor homolog: a gene essential for embryonic development encodes two receptor isoforms with different signaling potential. Fernández R, Tabarini D, Azpiazu N, Frasch M, Schlessinger J, EMBO J 1995 14 3373 3384 7628438
11. Structure and expression of the insulin-like peptide receptor from amphioxus. Pashmforoush M, Chan SJ, Steiner DF, Mol Endocrinol 1996 10 857 866 10.1210/me.10.7.857 8813726 (Pubitemid 26234624)
12. The taxonomy of developmental control in Caenorhabditis elegans. Ruvkun G, Hobert O, Science 1998 282 2033 2041 9851920 (Pubitemid 29001255)
13. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Cell 1985 40 747 758 10.1016/0092-8674(85)90334-4 2859121 (Pubitemid 15240280)
14. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Nature 1985 313 756 761 10.1038/313756a0 2983222 (Pubitemid 15130823)
15. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, EMBO J 1986 5 2503 2512 2877871
16. Primary structure of a putative receptor for a ligand of the insulin family. Shier P, Watt VM, J Biol Chem 1989 264 14605 14608 2768234 (Pubitemid 19237270)
17. Changes in insulin receptors during oral contraception. De Pirro R, Forte F, Bertoli A, Greco AV, Lauro R, J Clin Endocrinol Metab 1991 52 29 33
18. Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Mosthaf L, Vogt B, Haring HU, Ullrich A, Proc Natl Acad Sci USA 1991 88 4728 4730 10.1073/pnas.88.11.4728 1711209 (Pubitemid 21914615)
19. Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (noninsulin-dependent) diabetic subjects. Kellerer M, Sesti G, Seffer E, Obermaier-Kusser B, Pongratz DE, Diabetologia 1993 36 628 632 10.1007/BF00404072 8359580 (Pubitemid 23186455)
20. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Savkur RS, Philips AV, Cooper TA, Nat Genet 2001 29 40 47 10.1038/ng704 11528389 (Pubitemid 32801806)
21. Normal growth and development in the absence of hepatic insulin-like growth factor I. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Proc Natl Acad Sci USA 1999 96 7324 7329 10.1073/pnas.96.13.7324 10377413 (Pubitemid 29299660)
22. A single IGF1 allele is a major determinant of small size in dogs. Sutter NB, Bustamante CD, Chase K, Gray MM, Science 2007 316 112 115 10.1126/science.1137045 17412960 (Pubitemid 46559530)
23. Growth hormone receptor deficiency is associated with a major reduction in Pro-aging signaling, cancer, and diabetes in humans. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Sci Transl Med 2011 3 70ra13 10.1126/scitranslmed.3001845 21325617
24. Alanine scanning mutagenesis of a type 1 insulin-like growth factor receptor ligand binding site. Whittaker J, Groth AV, Mynarcik DC, Pluzek L, Gadsboll VL, Whittaker LJ, J Biol Chem 2001 276 43980 43986 10.1074/jbc. M102863200 11500492
25. Insulin and its receptor: structure, function and evolution. De Meyts P, Bioessays 2004 26 1351 1362 10.1002/bies.20151 15551269 (Pubitemid 39664629)
26. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Cancer Res 1993 53 3736 3740 8339284 (Pubitemid 23252035)
27. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Clin Cancer Res 1999 5 1935 1944 10430101 (Pubitemid 29334478)
28. The IGF system in thyroid cancer: new concepts. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Mol Pathol 2001 54 121 124 10.1136/mp.54.3.121 11376121 (Pubitemid 32539600)
29. Characterization of the insulin receptor kinase purified from human placental membranes. Kasuga M, Fujita-Yamaguchi Y, Blithe DL, White MF, Kahn CR, J Biol Chem 1983 258 10973 10980 6309826 (Pubitemid 13021262)
30. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with IRs. Soos MA, Siddle K, Biochem J 1989 263 553 563 2480779 (Pubitemid 19254161)
31. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in Transfected cells. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K, Biochem J 1990 270 383 390 1698059 (Pubitemid 20273478)
32. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Soos MA, Field CE, Siddle K, Biochem J 1993 290 419 426 8452530 (Pubitemid 23094937)
33. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM, Moller DE, Endocrinology 1991 129 2058 2066 10.1210/endo-129-4-2058 1655392
34. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Benyoucef S, Surinya KH, Hadaschik D, Siddle K, Biochem J 2007 403 603 613 10.1042/BJ20061709 17291192 (Pubitemid 46706989)
35. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A, J Biol Chem 2002 277 39684 39695 10.1074/jbc.M202766200 12138094 (Pubitemid 35190951)
36. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Mol Endocrinol 2004 18 2502 2512 10.1210/me.2004-0183 15205474 (Pubitemid 39335984)
37. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Oncogene 1999 18 2471 2479 10.1038/sj.onc.1202600 10229198 (Pubitemid 29206160)
38. Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A, J Biol Chem 2003 278 42178 42189 10.1074/jbc.M304980200 12881524 (Pubitemid 37310484)
39. ERK1/2 regulates epidermal chemokine expression and skin inflammation. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, Girolomoni G, J Immunol 2005 174 5047 5056 15814736
40. Quantum dot ligands reveal EGFR dynamics in living cells. Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post J, Grecco H, Nat Biotechnol 2004 22 198 203 10.1038/nbt929 14704683 (Pubitemid 38160535)
41. Quantitative studies of the rate of insulin internalization in isolated rat hepatocytes. Draznin B, Trowbridge M, Ferguson L, Biochem J 1984 218 307 312 6370239 (Pubitemid 14195527)
42. Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol ester. Hachiya HL, Takayama S, White MF, King GL, J Biol Chem 1987 262 6417 6424 3106355 (Pubitemid 17103052)
43. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern-Buell CL, Accili D, Gorden P, J Biol Chem 1995 270 24073 24077 10.1074/jbc.270.41.24073 7592607
44. Ligand-independent internalization and recycling of the insulin receptor. Effects of chronic treatment of 3T3-C2 fibroblasts with insulin and dexamethasone. Knutson VP, J Biol Chem 1992 267 931 937 1730683
45. Insulin and Insulin-like Growth Factor II Differentially regulate endocytic sorting and stability of insulin receptor isoform A. Morcavallo A, Genua M, Palummo A, Kletvikova E, Jiracek J, Brzozowski AM, Iozzo RV, Belfiore A, Morrione A, J Biol Chem 2012 287 11422 11436 10.1074/jbc.M111.252478 22318726
46. Pool of ligand bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization. Sorkin A, Eriksson A, Heldin CH, Westermark B, Claesson-Welsh L, J Cell Physiol 1993 156 373 382 10.1002/jcp.1041560221 7688373 (Pubitemid 23244102)
47. Endosomes, receptor tyrosine kinase internalization and signal transduction. Bergeron JJ, Di Guglielmo GM, Baass PC, Authier F, Posner BI, Biosci Rep 1995 15 411 418 10.1007/BF01204345 9156572 (Pubitemid 26153976)
48. Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization. Biener Y, Feinstein R, Mayak M, Kaburagi Y, Kadowaki T, Zick Y, J Biol Chem 1996 271 29489 29496 10.1074/jbc.271.46.29489 8910617 (Pubitemid 26382670)
49. Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes. Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, J Neurosci 1996 16 7950 7964 8987823 (Pubitemid 26405058)
50. Inhibition of clathrin mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Ceresa BP, Kao AW, Santeler SR, Pessin JE, Mol Cell Biol 1998 18 3862 3870 9632770 (Pubitemid 28287909)
51. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate- 1, but not for mitogen-activated protein kinase control. Parpal S, Karlsson M, Thorn H, Stralfors P, J Biol Chem 2001 276 9670 9678 10.1074/jbc.M007454200 11121405
52. An arginine to cysteine (252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalization but preserves signalling events. Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, Diabetologia 2002 45 657 667 10.1007/s00125-002-0798-5 12107746 (Pubitemid 34810690)
53. Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. Jensen M, Hansen B, De Meyts P, Schäffer L, Ursø B, J Biol Chem 2007 282 35179 35186 10.1074/jbc.M704599200 17925406 (Pubitemid 350232483)
54. Selective gene activation by spatial segregation of insulin receptor B signaling. Uhles S, Moede T, Leibiger B, Berggren PO, Leibiger IB, FASEB J 2007 21 1609 1621 10.1096/fj.06-7589com 17264162 (Pubitemid 46684862)
55. Molecular mechanisms of differential intracellular signaling from the insulin receptor. Jensen M, De Meyts P, Vitam Horm 2009 80 51 75 19251034
56. Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Hansen BF, Danielsen GM, Drejer K, Sørensen AR, Wiberg FC, Biochem J 1996 315 Pt 1 271 279 8670118 (Pubitemid 26113562)
57. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Diabetologia 1997 2 Suppl 40 25 S31
58. Timing-dependent modulation of insulin mitogenic versus metabolic signalling. De Meyts P, Shymko RM, Novartis Found Symp 2000 227 46 57 10752064
59. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Diabetes 2000 49 999 1005 10.2337/diabetes.49.6.999 10866053 (Pubitemid 30349423)